What Is Oral Leukoplakia—and How Is It Treated?

Oral leukoplakia is a common precancerous condition characterized by white, patchy lesions on the mucosal surfaces of the mouth—such as the tongue, buccal mucosa, floor of the mouth, or gums—that cannot be rubbed off and are not attributable to any other diagnosable disease. It is defined clinically and histopathologically as a predominantly keratinized epithelial change, often associated with chronic irritation, tobacco use (including smoking and smokeless forms), alcohol consumption, or human papillomavirus (HPV) infection.

While most cases remain stable or even regress spontaneously—particularly after removal of inciting factors such as cessation of tobacco use—a subset carries significant malignant potential. Approximately 3–6% of oral leukoplakias progress to oral squamous cell carcinoma over a 5- to 10-year period, with higher risks observed in non-homogeneous (speckled or nodular) variants, lesions located on the lateral tongue or floor of the mouth, and those exhibiting dysplasia on biopsy.

Diagnosis requires thorough clinical evaluation followed by incisional or excisional biopsy to rule out mimics—including lichen planus, candidiasis, frictional keratosis, and syphilitic glossitis—and to assess for epithelial dysplasia. Histopathologic grading (mild, moderate, or severe) informs risk stratification and management decisions.

Management is individualized and hinges on lesion characteristics, patient risk profile, and histologic findings. First-line intervention involves elimination of modifiable risk factors—especially tobacco and heavy alcohol use. For low-risk, homogeneous lesions without dysplasia, close clinical surveillance every 3–6 months is appropriate. In contrast, dysplastic or high-risk lesions typically warrant surgical excision—often via laser ablation or conventional scalpel surgery—with clear margins and long-term follow-up due to recurrence rates of up to 20–30%.

Patients diagnosed with oral leukoplakia require lifelong monitoring, given the persistent risk of recurrence and malignant transformation. Multidisciplinary care involving oral medicine specialists, oral and maxillofacial surgeons, and head and neck oncologists ensures optimal surveillance, early detection of progression, and timely intervention when indicated.